GlassScriptPhysician profile
Juraj Letko
NPI 1659547859
$3,833.61
in general payments reported to CMS, 2019-2025
9 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $49.06 · 2021: $216 · 2022: $203 · 2023: $254 · 2024: $2,408 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,668 · Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,668.49 |
| Food and Beverage | $1,202.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,034.97 | 2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,160.55 | 2019-2025 | Advantage System, Solyx Sis System, Upsylon |
| Coloplast Corp | $168.14 | 2023-2025 | Altis, Saffron |
| Abbvie INC. | $117.67 | 2019 | |
| Coopersurgical, INC. | $92.48 | 2019 | |
| Ferring Pharmaceuticals INC. | $87.36 | 2019 | |
| Applied Medical Resources Corporation | $80.99 | 2021 | |
| Medtronic, INC. | $68.20 | 2021-2022 | |
| Medical Device Business Services, INC. | $23.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juraj Letko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.